Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia

Clinical trial NCT00686010 · COMPLETED

Trial details

NCT number: NCT00686010
Sponsor: Japan Tobacco Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Hyperlipidaemia

Start date: 2000-05-01
Primary completion: 2001-01-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.